IL17A and congenital rubella syndrome: (ii) Delineate the pathways that were likely modulated by IL-17-deficiency that lead to higher mortality in DR3.IL-17° mice and pathways that might have contributed to higher survival in DR3.IFN-γ° mice following experimental SAg-induced CRS.